Attached files

file filename
EX-23.2 - EXHIBIT 23.2 - ASSEMBLY BIOSCIENCES, INC.v460245_ex23-2.htm
EX-31.2 - EXHIBIT 31.2 - ASSEMBLY BIOSCIENCES, INC.v460245_ex31-2.htm
EX-32.1 - EXHIBIT 32.1 - ASSEMBLY BIOSCIENCES, INC.v460245_ex32-1.htm
10-K - FORM 10-K - ASSEMBLY BIOSCIENCES, INC.v460245_10k.htm
EX-32.2 - EXHIBIT 32.2 - ASSEMBLY BIOSCIENCES, INC.v460245_ex32-2.htm
EX-31.1 - EXHIBIT 31.1 - ASSEMBLY BIOSCIENCES, INC.v460245_ex31-1.htm
EX-21 - EXHIBIT 21 - ASSEMBLY BIOSCIENCES, INC.v460245_ex21.htm
EX-10.12 - EXHIBIT 10.12 - ASSEMBLY BIOSCIENCES, INC.v460245_ex10-12.htm
EX-10.11 - EXHIBIT 10.11 - ASSEMBLY BIOSCIENCES, INC.v460245_ex10-11.htm

 

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in the following Registration Statements of Assembly Biosciences, Inc.:

 

(1)Registration Statement (Form S-8 No. 333-173613),
(2)Registration Statement (Form S-8 No. 333-182167),
(3)Registration Statement (Form S-8 No. 333-198803),
(4)Registration Statement (Form S-3 No. 333-208806),
(5)Registration Statement (Form S-8 No. 333-213019),

(6)Registration Statement (Form S-3 No. 333-200612)

 

of our report dated March 1, 2017, with respect to the consolidated financial statements of Assembly Biosciences, Inc. and Subsidiaries and the effectiveness of internal control over financial reporting of Assembly Biosciences, Inc. and Subsidiaries included in this Annual Report (Form 10-K) of Assembly Biosciences, Inc. and Subsidiaries for the year ended December 31, 2016.

 

/s/ Ernst & Young LLP  
Stamford, Connecticut  
March 1, 2017